Market Closed -
Hong Kong S.E.
04:08:17 2024-05-17 am EDT
|
5-day change
|
1st Jan Change
|
9.97
HKD
|
-0.10%
|
|
-2.25%
|
-35.68%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,906
|
7,175
|
4,700
|
-
|
-
|
Enterprise Value (EV)
1 |
8,974
|
7,379
|
5,194
|
5,339
|
5,382
|
P/E ratio
|
-26.1
x
|
-61.3
x
|
-25.4
x
|
-32.9
x
|
-118
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.3
x
|
11.6
x
|
6.51
x
|
5.05
x
|
3.36
x
|
EV / Revenue
|
17.4
x
|
11.9
x
|
7.19
x
|
5.74
x
|
3.85
x
|
EV / EBITDA
|
-36.6
x
|
-156
x
|
-71
x
|
-834
x
|
48.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
6.28
x
|
5.44
x
|
4.14
x
|
4.74
x
|
4.94
x
|
Nbr of stocks (in thousands)
|
509,278
|
509,278
|
509,278
|
-
|
-
|
Reference price
2 |
17.49
|
14.09
|
9.229
|
9.229
|
9.229
|
Announcement Date
|
3/27/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
516
|
618.1
|
722.5
|
930.4
|
1,399
|
EBITDA
1 |
-245.5
|
-47.17
|
-73.16
|
-6.403
|
110.9
|
EBIT
1 |
-318.3
|
-129.9
|
-177.7
|
-119.4
|
-1.444
|
Operating Margin
|
-61.7%
|
-21.02%
|
-24.59%
|
-12.84%
|
-0.1%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.6700
|
-0.2300
|
-0.3628
|
-0.2809
|
-0.0785
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
68.2
|
204
|
494
|
639
|
681
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.2779
x
|
-4.326
x
|
-6.751
x
|
-99.72
x
|
6.144
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-22.3%
|
-8.72%
|
-15.1%
|
-13.5%
|
-4.12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.790
|
2.590
|
2.230
|
1.950
|
1.870
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
122
|
104
|
215
|
110
|
110
|
Capex / Sales
|
23.61%
|
16.87%
|
29.78%
|
11.82%
|
7.86%
|
Announcement Date
|
3/27/23
|
3/25/24
|
-
|
-
|
-
|
Last Close Price
9.229
CNY Average target price
10.44
CNY Spread / Average Target +13.12% Consensus |
1st Jan change
|
Capi.
|
---|
| -35.68% | 651M | | -2.32% | 90.45B | | +3.68% | 41.45B | | -10.90% | 33.57B | | +58.05% | 25.73B | | -19.56% | 14.73B | | -9.06% | 12.82B | | -11.34% | 11.7B | | -43.53% | 11.44B | | +3.75% | 8.79B |
Biopharmaceuticals
|